Researchers found that urine AQP1 and PLIN2 were significantly upregulated in patients with ccRCC and papillary RCC (n = 47), showing high potential as screening biomarkers for RCC and a differential diagnostic tool for renal masses [25]. This evidence concerns the gene PLIN2 and nonpapillary renal cell carcinoma.